(Q37859676)

24 August 2017

1 reference

title

Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity (English)

1 reference

24 August 2017

main subject

cardiovascular disease

1 reference

1 reference

Henry R Kramer

1

1 reference

24 August 2017

Jon T Giles

series ordinal

2

1 reference

24 August 2017

language of work or name

1 reference

1 April 2011

1 reference

Arthritis Care and Research

24 August 2017

published in

1 reference

24 August 2017

volume

63

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

484-499

1 reference

The mortality of rheumatoid arthritis

24 August 2017

cites work

1 reference

21 January 2018

1 reference

Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.

21 January 2018

1 reference

Patterns of cardiovascular risk in rheumatoid arthritis

21 January 2018

1 reference

Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome

21 January 2018

1 reference

Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis

21 January 2018

1 reference

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis

21 January 2018

1 reference

Death rates and causes of death in patients with rheumatoid arthritis: a population-based study

21 January 2018

1 reference

Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s

21 January 2018

1 reference

Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study

21 January 2018

1 reference

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

21 January 2018

1 reference

Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study

21 January 2018

1 reference

Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy

21 January 2018

1 reference

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific

21 January 2018

1 reference

Trends in the leading causes of death in the United States, 1970-2002.

21 January 2018

1 reference

The widening mortality gap between rheumatoid arthritis patients and the general population

21 January 2018

1 reference

Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.

21 January 2018

1 reference

Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis

21 January 2018

1 reference

Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001.

21 January 2018

1 reference

Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis

21 January 2018

1 reference

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

21 January 2018

1 reference

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

21 January 2018

1 reference

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

21 January 2018

1 reference

Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis

21 January 2018

1 reference

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity

21 January 2018

1 reference

Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages

21 January 2018

1 reference

Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

21 January 2018

1 reference

Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis

21 January 2018

1 reference

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity

21 January 2018

1 reference

Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis

21 January 2018

1 reference

Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis.

21 January 2018

1 reference

Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media

21 January 2018

1 reference

Preclinical carotid atherosclerosis in patients with rheumatoid arthritis

21 January 2018

1 reference

Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation

21 January 2018

1 reference

Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.

21 January 2018

1 reference

Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis?

21 January 2018

1 reference

Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment.

21 January 2018

1 reference

Cardiovascular risk factors, fitness and physical activity in rheumatic diseases

21 January 2018

1 reference

Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis.

21 January 2018

1 reference

No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

21 January 2018

1 reference

No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.

21 January 2018

1 reference

Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis.

21 January 2018

1 reference

The lag time between onset of symptoms and diagnosis of rheumatoid arthritis.

21 January 2018

1 reference

Rheumatoid arthritis and macrovascular disease

21 January 2018

1 reference

Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis.

21 January 2018

1 reference

Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients

21 January 2018

1 reference

C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis

21 January 2018

1 reference

Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis

21 January 2018

1 reference

Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis

21 January 2018

1 reference

Augmentation index and large-artery remodeling in patients with longstanding rheumatoid arthritis compared with healthy controls.

21 January 2018

1 reference

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis).

21 January 2018

1 reference

Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores

21 January 2018

1 reference

Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice

21 January 2018

1 reference

Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice

21 January 2018

1 reference

Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis

21 January 2018

1 reference

An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Cardiovascular risk factors in women with and without rheumatoid arthritis

21 January 2018

1 reference

Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis

21 January 2018

1 reference

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

21 January 2018

1 reference

Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones

21 January 2018

1 reference

Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance.

21 January 2018

1 reference

Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms

21 January 2018

1 reference

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

21 January 2018

1 reference

Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis.

21 January 2018

1 reference

Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis

21 January 2018

1 reference

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

21 January 2018

1 reference

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease

21 January 2018

1 reference

Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis

21 January 2018

1 reference

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists

21 January 2018

1 reference

Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis

21 January 2018

1 reference

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

21 January 2018

1 reference

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.

21 January 2018

1 reference

TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.

21 January 2018

1 reference

Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade

21 January 2018

1 reference

Infliximab improves vascular stiffness in patients with rheumatoid arthritis

21 January 2018

1 reference

Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy

21 January 2018

1 reference

Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody

21 January 2018

1 reference

Glucocorticoids and cardiovascular disease

21 January 2018

1 reference

Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease

21 January 2018

1 reference

Effect of glucocorticoids on the arteries in rheumatoid arthritis

21 January 2018

1 reference

Lower limb arterial incompressibility and obstruction in rheumatoid arthritis

21 January 2018

1 reference

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

21 January 2018

1 reference

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis

21 January 2018

1 reference

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis.

21 January 2018

1 reference

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis

21 January 2018

1 reference

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

21 January 2018

1 reference

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

21 January 2018

1 reference

Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis

21 January 2018

1 reference

Effect of anti–tumor necrosis factor α therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis

21 January 2018

1 reference

The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years

21 January 2018

1 reference

Intravascular tumor necrosis factor α blockade reverses endothelial dysfunction in rheumatoid arthritis

21 January 2018

1 reference

Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.20386

1 reference

24 August 2017

1 reference